AllianceBernstein’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,424
| Closed | -$139K | – | 3374 |
|
|
2022
Q1 | $139K | Buy |
1,424
+5
| +0.4% | +$642 | ﹤0.01% | 3070 |
|
|
2021
Q4 | $232K | Sell |
1,419
-113
| -7% | -$24.8K | ﹤0.01% | 3021 |
|
|
2021
Q3 | $418K | Sell |
1,532
-70
| -4% | -$21.4K | ﹤0.01% | 2825 |
|
|
2021
Q2 | $634K | Buy |
1,602
+150
| +10% | +$70K | ﹤0.01% | 2715 |
|
|
2021
Q1 | $784K | Buy |
1,452
+272
| +23% | +$169K | ﹤0.01% | 2499 |
|
|
2020
Q4 | $446K | Sell |
1,180
-204
| -15% | -$81.1K | ﹤0.01% | 2644 |
|
|
2020
Q3 | $523K | Sell |
1,384
-84
| -6% | -$37.1K | ﹤0.01% | 2504 |
|
|
2020
Q2 | $722K | Buy |
1,468
+58
| +4% | +$25.9K | ﹤0.01% | 2382 |
|
|
2020
Q1 | $518K | Sell |
1,410
-68
| -5% | -$35.2K | ﹤0.01% | 2338 |
|
|
2019
Q4 | $1.05M | Sell |
1,478
-78
| -5% | -$53.7K | ﹤0.01% | 2261 |
|
|
2019
Q3 | $999K | Hold |
1,556
| – | – | ﹤0.01% | 2247 |
|
|
2019
Q2 | $1.36M | Sell |
1,556
-27
| -2% | -$18.6K | ﹤0.01% | 2177 |
|
|
2019
Q1 | $914K | Sell |
1,583
-263
| -14% | -$110K | ﹤0.01% | 2281 |
|
|
2018
Q4 | $518K | Sell |
1,846
-6
| -0.3% | -$2.37K | ﹤0.01% | 2464 |
|
|
2018
Q3 | $889K | Buy |
1,852
+291
| +19% | +$125K | ﹤0.01% | 2385 |
|
|
2018
Q2 | $707K | Buy |
1,561
+264
| +20% | +$167K | ﹤0.01% | 2471 |
|
|
2018
Q1 | $763K | Hold |
1,297
| – | – | ﹤0.01% | 2374 |
|
|
2017
Q4 | $805K | Hold |
1,297
| – | – | ﹤0.01% | 2384 |
|
|
2017
Q3 | $1.19M | Hold |
1,297
| – | – | ﹤0.01% | 2182 |
|
|
2017
Q2 | $1.21M | Hold |
1,297
| – | – | ﹤0.01% | 2202 |
|
|
2017
Q1 | $1.23M | Hold |
1,297
| – | – | ﹤0.01% | 2134 |
|
|
2016
Q4 | $1.04M | Hold |
1,297
| – | – | ﹤0.01% | 2244 |
|
|
2016
Q3 | $1.09M | Hold |
1,297
| – | – | ﹤0.01% | 2178 |
|
|
2016
Q2 | $1.07M | Hold |
1,297
| – | – | ﹤0.01% | 2178 |
|
|
2016
Q1 | $1.44M | Buy |
1,297
+17
| +1% | +$17.4K | ﹤0.01% | 1867 |
|
|
2015
Q4 | $1.6M | Sell |
1,280
-20
| -2% | -$33.1K | ﹤0.01% | 1805 |
|
|
2015
Q3 | $1.76M | Sell |
1,300
-1
| -0.1% | -$1.65K | ﹤0.01% | 1752 |
|
|
2015
Q2 | $2.34M | Buy |
1,301
+487
| +60% | +$756K | ﹤0.01% | 1658 |
|
|
2015
Q1 | $1.31M | Buy |
814
+167
| +26% | +$248K | ﹤0.01% | 2031 |
|
|
2014
Q4 | $492K | Hold |
647
| – | – | ﹤0.01% | 2518 |
|
|
2014
Q3 | $256K | Hold |
647
| – | – | ﹤0.01% | 2697 |
|
|
2014
Q2 | $391K | Buy |
647
+60
| +10% | +$33.4K | ﹤0.01% | 2589 |
|
|
2014
Q1 | $403K | Sell |
587
-96
| -14% | -$64.3K | ﹤0.01% | 2516 |
|
|
2013
Q4 | $445K | Hold |
683
| – | – | ﹤0.01% | 2486 |
|
|
2013
Q3 | $405K | Sell |
683
-89
| -12% | -$40.1K | ﹤0.01% | 2574 |
|
|
2013
Q2 | $243K | Buy |
+772
| New | +$214K | ﹤0.01% | 2789 |
|
Other funds holding TCRT
MP
DCM
LCM
AllianceBernstein's TCRT Position: Q2 2022 in Review
AllianceBernstein sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 1,424 shares — an estimated $139K sold.
AllianceBernstein first reported a position in TCRT in Q2 2013 and held it in 36 quarters. The position peaked at $2.34M in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- AllianceBernstein reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- AllianceBernstein sold 1,424 Alaunos Therapeutics shares in Q2 2022, an estimated $139K.
- AllianceBernstein first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 36 quarters.
- AllianceBernstein's Alaunos Therapeutics position peaked at $2.34M in Q2 2015.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.